Team information | ||
---|---|---|
UCI code | GES | |
Registered |
| |
Founded | 1996 | |
Discipline(s) | Road | |
Status |
| |
Bicycles | Bottecchia | |
Website | Team home page | |
Key personnel | ||
General manager | Gianni Savio | |
Team name history | ||
1996 1997â1998 1999 2000 2001 2002â2005 2006 2007 2008â2009 2010â2011 2012â2014 2015 2016â2017 2017 2018â2021 2022 2023 2024â | Gaseosas GlacialâSelle Italia KrossâSelle Italia Selle Italia Aguardiente NĂ©ctarâSelle Italia Selle ItaliaâPacific ColombiaâSelle Italia Selle ItaliaâSerramenti Diquigiovanni Serramenti PVC DiquigiovanniâSelle Italia Serramenti PVC DiquigiovanniâAndroni Giocattoli Androni Giocattoli Androni GiocattoliâVenezuela AndroniâSidermec Androni GiocattoliâSidermec AndroniâSidermecâBottecchia Androni GiocattoliâSidermec Drone HopperâAndroni Giocattoli GWâShimanoâSidermec GW Erco Shimano | |
| ||
GW Erco Shimano ( UCI team code: GES) is a Colombian-registered UCI Continental cycling team that participates in road bicycle racing events on the UCI Continental Circuits. Prior to 2023, the team was based in Italy and held UCI ProTeam status. Gianni Savio manages the team, with assistance from directeurs sportifs Giovanni Ellena, Antonio Castano, Didier Paindaveine and Marco Bellini.
In 2022, with the arrival of a new sponsor â Drone Hopper (an aeronautical engineering company based in Spain) â the team has received a new name Drone HopperâAndroni Giocattoli. [1]
On 5 June 2014 Patrick Facchini gave an adverse analytical finding for Tuaminoheptane and was consequently banned for 10 months. [2]
On 30 June 2015 Davide Appollonio gave an adverse analytical finding for EPO and was provisionally suspended. [3] On 27 July 2015 Fabio Taborre gave a positive test result for the banned blood-booster FG-4592 in an out-of-competition control on 16 June. The team were automatically suspended by the UCI under new rules. [4] FG-4592 ( Roxadustat) is in phase 3 clinical trials and has not yet been commercialised. The drug was developed jointly by FibroGen and AstraZeneca. Unlike EPO, which directly stimulates the production of red blood cells, FG-4592 is taken orally, and stimulates natural production of EPO in a manner similar to altitude training. [5] This class of compounds has been outlawed by WADA. The UCI subsequently suspended the team for 30 days. [6]
|
|
Team information | ||
---|---|---|
UCI code | GES | |
Registered |
| |
Founded | 1996 | |
Discipline(s) | Road | |
Status |
| |
Bicycles | Bottecchia | |
Website | Team home page | |
Key personnel | ||
General manager | Gianni Savio | |
Team name history | ||
1996 1997â1998 1999 2000 2001 2002â2005 2006 2007 2008â2009 2010â2011 2012â2014 2015 2016â2017 2017 2018â2021 2022 2023 2024â | Gaseosas GlacialâSelle Italia KrossâSelle Italia Selle Italia Aguardiente NĂ©ctarâSelle Italia Selle ItaliaâPacific ColombiaâSelle Italia Selle ItaliaâSerramenti Diquigiovanni Serramenti PVC DiquigiovanniâSelle Italia Serramenti PVC DiquigiovanniâAndroni Giocattoli Androni Giocattoli Androni GiocattoliâVenezuela AndroniâSidermec Androni GiocattoliâSidermec AndroniâSidermecâBottecchia Androni GiocattoliâSidermec Drone HopperâAndroni Giocattoli GWâShimanoâSidermec GW Erco Shimano | |
| ||
GW Erco Shimano ( UCI team code: GES) is a Colombian-registered UCI Continental cycling team that participates in road bicycle racing events on the UCI Continental Circuits. Prior to 2023, the team was based in Italy and held UCI ProTeam status. Gianni Savio manages the team, with assistance from directeurs sportifs Giovanni Ellena, Antonio Castano, Didier Paindaveine and Marco Bellini.
In 2022, with the arrival of a new sponsor â Drone Hopper (an aeronautical engineering company based in Spain) â the team has received a new name Drone HopperâAndroni Giocattoli. [1]
On 5 June 2014 Patrick Facchini gave an adverse analytical finding for Tuaminoheptane and was consequently banned for 10 months. [2]
On 30 June 2015 Davide Appollonio gave an adverse analytical finding for EPO and was provisionally suspended. [3] On 27 July 2015 Fabio Taborre gave a positive test result for the banned blood-booster FG-4592 in an out-of-competition control on 16 June. The team were automatically suspended by the UCI under new rules. [4] FG-4592 ( Roxadustat) is in phase 3 clinical trials and has not yet been commercialised. The drug was developed jointly by FibroGen and AstraZeneca. Unlike EPO, which directly stimulates the production of red blood cells, FG-4592 is taken orally, and stimulates natural production of EPO in a manner similar to altitude training. [5] This class of compounds has been outlawed by WADA. The UCI subsequently suspended the team for 30 days. [6]
|
|